July 19, 2019 / 5:16 PM / 4 months ago

BRIEF-Gilead Sciences Licenses Respiratory, Herpes Antiviral Research Programs From Novartis

July 19 (Reuters) - Gilead Sciences Inc:

* GILEAD SCIENCES LICENSES RESPIRATORY AND HERPES ANTIVIRAL RESEARCH PROGRAMS FROM NOVARTIS

* GILEAD SCIENCES INC - GILEAD WILL ACQUIRE EXCLUSIVE GLOBAL RIGHTS TO DEVELOP AND COMMERCIALIZE NOVEL SMALL MOLECULES AGAINST THREE UNDISCLOSED TARGETS

* GILEAD-NOVARTIS TO RECEIVE UPFRONT PAYMENT & IS ELIGIBLE TO RECEIVE UP TO $291 MILLION IN MILESTONE PAYMENTS UPON ACHIEVEMENT OF CERTAIN MILESTONES

* GILEAD SCIENCES - NOVARTIS IS ALSO ELIGIBLE TO RECEIVE ROYALTIES ON ANNUAL NET SALES UNDER AGREEMENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below